Streetbeat News

Regulatory

ALRS

HMNF

Alerus Financial has received all necessary regulatory approvals to complete its acquisition of HMN Financial.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:21 pm

MNTS

Momentus Inc. has received a non-compliance notice from the Nasdaq Listing Qualifications Department, indicating that the company is not meeting certain listing requirements. This could potentially impact the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:17 pm

CMPS

A study from Columbia University suggests psilocybin, found in magic mushrooms, may help treat body dysmorphic disorder (BDD). Supported by COMPASS Pathways, the study showed improved brain connectivity and symptom relief in BDD patients using COMP360, a synthetic psilocybin formulation.

Portfolio Pulse from Juan Spínelli

September 26, 2024 | 9:13 pm

DKNG

The U.S. SEC has charged DraftKings for selectively disclosing nonpublic information through the CEO's social media accounts.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:22 pm

HOOD

PYPL

Robinhood and Revolut are reportedly considering launching their own stablecoins, potentially challenging Tether's dominance in the $170 billion market. This move comes as the EU prepares to implement new crypto regulations, which could impact Tether's operations. Meanwhile, PayPal is expanding its crypto offerings.

Portfolio Pulse from Ivan Crnogatić

September 26, 2024 | 8:11 pm

CRNX

Crinetics Pharmaceuticals has submitted a New Drug Application to the FDA for paltusotine, a novel treatment for acromegaly. This marks a significant step for the company in advancing its drug pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:10 pm

QGEN

QIAGEN has received European IVDR certification for its QIAstat-Dx syndromic testing instruments and assays, marking a significant regulatory milestone. This certification allows QIAGEN to continue marketing these products in Europe, potentially boosting their market presence and sales.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:10 pm

WLDS

Wearable Devices has filed a patent application with the Korean Intellectual Property Office for a gesture and voice-controlled interface device. This move is part of their strategy to expand global protection of their core intellectual property.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:05 pm

TVTX

Travere Therapeutics has voluntarily paused enrollment in its Phase 3 HARMONY study of Pegtibatinase to address necessary process improvements in manufacturing scale-up. This pause is intended to support commercial scale manufacturing and full enrollment in the study.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:02 pm

ALLR

Allarity Therapeutics has been granted a European patent for methods predicting drug responsiveness in cancer patients. This development could enhance their drug development process and potentially improve treatment outcomes.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 7:59 pm